The probiotic compound VSL#3 has an extensive impact on mucosal, peripheral, and systemic innate as well as adaptive immunity, exerting beneficial anti-inflammatory effects in intestinal as well as systemic compartments. Hence VSL#3 might be considered a therapeutic immunomodulatory tool following a
Prof. Antonio Gasbarrini is Professor at Università Cattolica del Sacro Cuore and Director of the Specialization school of Gastroenterology and Digestive Endoscopy of Policlinico Gemelli, in Rome.
Discussing on the world of Microbiota and Gut microbiota we asked him to explaine us what is a Micr
VSL#3 will take part in XVIII Convegno Nazionale ANSISA host to NH Hotel in Assago Milano.
On November 17th -18th ANSISA 's national congress (National Association of specialists in Nutritional science) will be focus on Clinical nutrition.
As part of the plenary session on Elements of integrat
@ Copyright 2016. VAT number Actial Farmaceutica srl IT14019081000